Residual range‐based quenching correction for Gafchromic EBT3 film in proton therapy patient‐specific QA
Journal of Applied Clinical Medical Physics · 2025
DOI: 10.1002/acm2.70376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Ting-Chun Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Proton Therapy, Film Dosimetry, Quality Assurance, Health Care, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Gafchromic EBT3 film is a widely used dosimeter in radiotherapy due to its high spatial resolution and near tissue equivalence. However, its application in proton therapy is limited by the linear energy transfer (LET) quenching effect, particularly in the Bragg peak region.
Purpose
This study proposes a correction method based on residual range ( R res ) to quantify and mitigate this quenching effect for improved accuracy in patient‐specific quality assurance (PSQA) and related research.
Methods
We defined a quenching factor (QF) as the ratio of dose measured with a Markus ionization chamber to that measured with EBT3 film. The EBT film calibration curve is established by measurements in the plateau region of the depth‐dose distribution of a monoenergetic proton reference beam. A series of proton treatment plans with varying spread‐out Bragg peaks (SOBPs) were designed to examine QF across different residual ranges. A correction function correlating R res to QF was derived. Clinical verifications of patient‐specific QA were performed by comparing EBT3 measurements, with and without QF correction, to MatriXX‐PT and Eclipse TPS calculations.
Results
The EBT3 film underestimated dose by approximately 7% at an R res of 1.4 cm. A clear dependence of film response on R res was observed: as R res decreased, the degree of under‐response increased. A correction function was established based on the relationship between R res and QF, enabling accurate dose reconstruction. The dose map measured using QF‐calibrated EBT3 film showed good agreement with the TPS‐calculated data, and the discrepancies between the EBT3 film measurements, MatriXX‐PT measurements, and TPS calculations were significantly reduced in regions with smaller R res values.
Conclusion
We proposed and validated a clinically applicable correction function for EBT3 film quenching in proton PSQA. This approach offers a practical and cost‐effective solution for both clinical and research applications involving proton dosimetry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
- Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.
- Department of Medicine, China Medical University, Taichung, Taiwan.
- Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan.
Zitieren
APA
Lin, T. C., Hsu, H. T., Chen, Y. F., Chiou, Y. R., Liang, J. A., & Shiau, A. C. (2025). Residual range‐based quenching correction for Gafchromic EBT3 film in proton therapy patient‐specific QA. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70376
Vancouver
Lin TC, Hsu HT, Chen YF, Chiou YR, Liang JA, Shiau AC. Residual range‐based quenching correction for Gafchromic EBT3 film in proton therapy patient‐specific QA. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.70376
BibTeX
@article{Lin2025,
author = {Lin, Ting-Chun and Hsu, Hsiu-Ting and Chen, Yu-Fen and Chiou, Yu-Rou and Liang, Ji-An and Shiau, An-Cheng},
title = {Residual range‐based quenching correction for Gafchromic EBT3 film in proton therapy patient‐specific QA},
journal = {Journal of Applied Clinical Medical Physics},
year = {2025},
doi = {10.1002/acm2.70376}
}
EUVIMED